ArticleBMC medicine2023

A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.

Hai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.